Sigma-1 receptor implicated in cell survival of rare neurodegenerative diseases

Anavex Life Sciences Corp. has announced that a publication in the current issue of scientific journal Neuropathology potentially extends the opportunity for ANAVEX PLUS to additional neurodegenerative diseases beyond Alzheimer’s. Read & Research Alzheimer’s More

Leave a Reply